Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation

Bibliographic Details
Main Authors: Shiqi Mao, Libo Luo, Shuo Yang, Yan Wang, Fei Zhou, Jia Yu, Bin Chen, Guanghui Gao, Xuefei Li, Chao Zhao, Lei Cheng, Yiwei Liu, Wanying Wang, Keyi Jia, Chuchu Shao, Xinyu Liu, Xiaoxia Chen, Chunxia Su, Caicun Zhou, Fengying Wu, Shengxiang Ren, Xiangxiang Pan, Peifang Wei
Format: Article
Language:English
Published: Wolters Kluwer 2023-04-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002453
Description
ISSN:0366-6999
2542-5641

Similar Items